Hantz Financial Services Inc. Purchases 139 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Hantz Financial Services Inc. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,419 shares of the company’s stock after buying an additional 139 shares during the period. Hantz Financial Services Inc.’s holdings in HCA Healthcare were worth $6,267,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. FMR LLC boosted its holdings in shares of HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after buying an additional 2,397,883 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in HCA Healthcare by 2.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock valued at $604,511,000 after purchasing an additional 41,190 shares during the period. Darsana Capital Partners LP boosted its holdings in HCA Healthcare by 53.3% in the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after purchasing an additional 400,000 shares during the period. TD Asset Management Inc boosted its holdings in HCA Healthcare by 2.7% in the 2nd quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after purchasing an additional 19,812 shares during the period. Finally, Epoch Investment Partners Inc. boosted its holdings in HCA Healthcare by 16.4% in the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after purchasing an additional 88,948 shares during the period. 62.73% of the stock is owned by institutional investors.

Analysts Set New Price Targets

HCA has been the subject of a number of research reports. Royal Bank of Canada increased their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Morgan Stanley began coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective for the company. Finally, Barclays dropped their price objective on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $380.29.

Insider Activity

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Trading Up 0.5 %

HCA opened at $327.24 on Friday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The stock has a market capitalization of $82.89 billion, a PE ratio of 14.69, a PEG ratio of 1.25 and a beta of 1.68. HCA Healthcare, Inc. has a 1-year low of $246.60 and a 1-year high of $417.14. The firm has a 50-day moving average price of $371.88 and a two-hundred day moving average price of $358.35.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.